Most Clicked StoriesMore >


Study rejects link between DPP-4 inhibitors, pancreatic cancer risk in diabetes

DiabetesPro SmartBrief | Sep 26, 2014

An analysis of Medicare claims data found that use of dipeptidyl-peptidase-4 inhibitors for glycemic control does not appear to increase the odds of short-term pancreatic cancer risk compared with sulfonylureas and thiazolidinediones. The findings are reported in the journal Diabetes, Obesity and Metabolism. DoctorsLounge.com (09/22)


Omarigliptin, sitagliptin show comparable diabetes outcomes

DiabetesPro SmartBrief | Sep 23, 2014

Roche's glucose monitor with insulin calculator wins FDA nod

DiabetesPro SmartBrief | Sep 23, 2014

Better diabetes outcomes seen with degludec/liraglutide combo

DiabetesPro SmartBrief | Sep 24, 2014

Treatment combo boosts A1C control in type 2 diabetes

DiabetesPro SmartBrief | Sep 23, 2014

Canagliflozin yields weight loss, study finds

DiabetesPro SmartBrief | Sep 26, 2014

Study examines effects of glucose control on type 2 diabetes

DiabetesPro SmartBrief | Sep 24, 2014

U.S. sees decline in new diabetes cases, CDC finds

DiabetesPro SmartBrief | Sep 24, 2014

Diabetes patients on biguanides, liraglutide show lower heart risks

DiabetesPro SmartBrief | Sep 25, 2014

Metformin may lead to low TSH in patients with diabetes, hypothyroidism

DiabetesPro SmartBrief | Sep 23, 2014


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Free CME/CE opportunity: Webcasts from Diabetes is Primary

DiabetesPro SmartBrief | Sep 29, 2014

ConnecT2Day: Innovative Program Providing Key Insights and Tools for Health Care Professionals

DiabetesPro SmartBrief | Sep 26, 2014

New Child Care Position Statement & Resources!

DiabetesPro SmartBrief | Sep 25, 2014

Become a recognized education program through the American Diabetes Association

DiabetesPro SmartBrief | Sep 24, 2014

Continuing education for health care professionals who treat patients with diabetes

DiabetesPro SmartBrief | Sep 22, 2014




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


What type of continuing education opportunities do you participate in most?

Chart.